대한영상의학회지 (Journal of the Korean Society of Radiology)

  • 제64권5호
  • /
  • Pages.449-455
  • /
  • 2011
  • /
  • 1738-2637(pISSN)
  • /
  • 2951-0805(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지

자궁근종과 자궁선근증 치료를 위한 자궁동맥색전술 후 24시간 이내의 통증 조절에 대한 경피 펜타닐 패치의 효과

Comparison of an Additional Transdermal Fentanyl Patch Compared to Intravenous NSAID and Opioid Analgesics within 24 Hours of an Uterine Artery Embolization for Myoma and Adenomyosis

  • 송숙연 (이화여자대학교 의과대학 목동병원 영상의학과) ;
  • 강병철 (이화여자대학교 의과대학 목동병원 영상의학과) ;
  • 노경민 (이화여자대학교 의과대학 목동병원 영상의학과)
  • Song, Sook-Yun (Department of Radiology, Mokdong Hospital, Ewha Womans University School of Medicine) ;
  • Kang, Byung-Chul (Department of Radiology, Mokdong Hospital, Ewha Womans University School of Medicine) ;
  • Rho, Kyung-Min (Department of Radiology, Mokdong Hospital, Ewha Womans University School of Medicine)
  • 발행 : 2011.05.01
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 자궁근종과 자궁선근증 환자에서 자궁동맥색전술 시행 후 통증의 정도를 24시간 동안 평가하여 정맥 내 진통제와 함께 추가로 사용하는 경피 펜타닐 패치의 통증 조절에 대한 효과를 알아보았다. 대상과 방법: 자궁근종과 자궁선근증으로 자궁동맥색전술을 시행 받은 42명의 환자를 대상으로, 마약성 진통제 페티딘과 비스테로이드성 소염제를 정맥 내 투여받은 군(A군)과 추가로 경피 펜타닐 패치를 부착한 군(B군)으로 각각 21명씩 분류하였다. 색전술 시행 후 24시간 동안의 통증지각 정도를 구두통증척도에 따라 0-10점으로 평가하여 시간에 따른 통증 정도를 분석하였다. 또한, 두 군의 통증 정도, 페티딘 투여량, 부작용 발생을 비교하였다. 결과: 전체 환자에서 색전술 6시간 후에 통증의 정도가 가장 심했으며, 이때의 평균 구두통증척도는 A군 8.2 ${\pm}$ 0.7점, B군 6.3 ${\pm}$ 0.7점으로 유의한 차이가 있었다(p < 0.05). A군에서는 평균 114.3 ${\pm}$ 59.5 mg의 페티딘이 투여되었고 B군에서는 평균 90.5 ${\pm}$ 49.0 mg이 투여되었으나, 유의한 차이는 없었다(p=0.131). 오심의 발생은 A군에서 67%, B군에서 77%였으며 유의한 차이는 없었다(p=0.495). 호흡장애는 발생하지 않았다. 결론: 자궁동맥색전술 시행 후 24시간 이내의 통증 조절에 정맥 내 진통제에 추가로 경피 펜타닐 패치를 사용하는 것은 효과적이며 심각한 부작용을 일으키지 않았다.

Purpose: To evaluate the effectiveness of an additional transdermal fentanyl patch compared to intravenous analgesics in pain control during the 24-hour period following uterine artery embolization (UAE) for myoma and adenomyosis. Materials and Methods: Between September 2009 and August 2010, 42 patients underwent UAE for myoma or adenomyosis. Of these, 21 received an intravenous opioid (pethidine) and a nonsteroidal anti-inflammatory drug (group A), and 21 received an additional transdermal fentanyl patch (group B). Pain perception levels were established verbally on a 0-10 scale during the 24-hour period following UAE. Differences in pain trends, mean dose of intravenous pethidine, and adverse effects were compared between the two groups. Results: Pain perception was most severe at 6 hours after UAE and the mean pain level of group B at that time was 6.3 ${\pm}$ 0.7, which was significantly lower than that of group A, 8.2 ${\pm}$ 0.7 (p<0.05). The mean dose of intravenous pethidine was 114.3 ${\pm}$ 59.5 mg in group A and 90.5 ${\pm}$ 49.0 mg in group B, while the incidence of nausea was 67% in group A and 77% in group B. In both cases, the differences were not significantly different (p>0.05), and no evidence of respiratory distress was demonstrated. Conclusion: The addition of a transdermal fentanyl patch to intravenous analgesics is effective in reducing post-embolization pain during the 24-hour period after UAE.

키워드

참고문헌

  1. Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. Lancet 1995;346:671-672 https://doi.org/10.1016/S0140-6736(95)92282-2
  2. Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging followup. BJOG 2002;109:1262-1272 https://doi.org/10.1046/j.1471-0528.2002.01449.x
  3. Pron G, Bennett J, Common A, Wall J, Asch M, Sniderman K, et al. The ontario uterine fibroid embolization trial. part 2. uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003;79:120-127 https://doi.org/10.1016/S0015-0282(02)04538-7
  4. Spies JB, Bruno J, Czeyda-Pommersheim F, Magee ST, Ascher SA, Jha RC. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 2005;106:933-939 https://doi.org/10.1097/01.AOG.0000182582.64088.84
  5. Kim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, et al. Longterm results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol 2007;188:176-181 https://doi.org/10.2214/AJR.05.1613
  6. Lohle PN, De Vries J, Klazen CA, Boekkooi PF, Vervest HA, Smeets AJ, et al. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up. J Vasc Interv Radiol 2007;18:835-841 https://doi.org/10.1016/j.jvir.2007.04.024
  7. Pron G, Mocarski E, Bennett J, Vilos G, Common A, Zaidi M, et al. Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the ontario uterine fibroid embolization trial. J Vasc Interv Radiol 2003;14:1243-1250 https://doi.org/10.1097/01.RVI.0000092664.72261.F9
  8. Hehenkamp WJ, Volkers NA, Birnie E, Reekers JA, Ankum WM. Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Cardiovasc Intervent Radiol 2006;29:179-187 https://doi.org/10.1007/s00270-005-0195-9
  9. Kim HS, Czuczman GJ, Nicholson WK, Pham LD, Richman JM. Pain levels within 24 hours after UFE: a comparison of morphine and fentanyl patient-controlled analgesia. Cardiovasc Intervent Radiol 2008;31:1100-1107 https://doi.org/10.1007/s00270-008-9430-5
  10. Siskin GP, Bonn J, Worthington-Kirsch RL, Smith SJ, Shlansky-Goldberg R, Machan LS, et al. III. uterine fibroid embolization: Pain management. Tech Vasc Interv Radiol 2002;5:35-43 https://doi.org/10.1053/tvir.2002.124727
  11. Lampmann LE, Lohle PN, Smeets A, Boekkooi PF, Vervest H, van Oirschot CM, et al. Pain management during uterine artery embolization for symptomatic uterine fibroids. Cardiovasc Intervent Radiol 2007;30:809-811 https://doi.org/10.1007/s00270-007-9069-7
  12. Kornick CA, Santiago-Palma J, Moryl N, Payne R, Obbens EA. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf 2003;26:951-973 https://doi.org/10.2165/00002018-200326130-00004
  13. Kornick CA, Santiago-Palma J, Moryl N, Payne R, Obbens EA. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf 2003;26:951-973 https://doi.org/10.2165/00002018-200326130-00004
  14. Minville V, Lubrano V, Bounes V, Pianezza A, Rabinowitz A, Gris C, et al. Postoperative analgesia after total hip arthroplasty: patient-controlled analgesia versus transdermal fentanyl patch. J Clin Anesth 2008;20:280-283 https://doi.org/10.1016/j.jclinane.2007.12.013
  15. Spies JB, Cooper JM, Worthington-Kirsch R, Lipman JC, Mills BB, Benenati JF. Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 2004;191:22-31 https://doi.org/10.1016/j.ajog.2004.03.037
  16. Goodwin SC, Bradley LD, Lipman JC, Stewart EA, Nosher JL, Sterling KM, et al. Uterine artery embolization versus myomectomy: a multicenter comparative study. Fertil Steril 2006;85:14-21
  17. Siskin GP, Shlansky-Goldberg RD, Goodwin SC, Sterling K, Lipman JC, Nosher JL, et al. A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. J Vasc Interv Radiol 2006;17:1287-1295 https://doi.org/10.1097/01.RVI.0000231953.91787.AF
  18. Bruno J, Sterbis K, Flick P, McCullough M, Cramp M, Murphy-Skrynarz K, et al. Recovery after uterine artery embolization for leiomyomas: a detailed analysis of its duration and severity. J Vasc Interv Radiol 2004;15:801-807 https://doi.org/10.1097/01.RVI.0000136983.45640.E4
  19. Keyoung JA, Levy EB, Roth AR, Gomez-Jorge J, Chang TC, Spies JB. Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata. J Vasc Interv Radiol 2001;12:1065-1069 https://doi.org/10.1016/S1051-0443(07)61592-9
  20. Pisco JM, Bilhim T, Duarte M, Ferreira A, Santos D, Pires FM, et al. Pelvic pain after uterine artery embolization: a prospective randomized study of polyvinyl alcohol particles mixed with ketoprofen versus bland polyvinyl alcohol particles. J Vasc Interv Radiol 2008;19:1537-1542 https://doi.org/10.1016/j.jvir.2008.07.015
  21. Ryu RK, Omary RA, Sichlau MJ, Siddiqi A, Chrisman HB, Nemcek AA Jr, et al. Comparison of pain after uterine artery embolization using tris-acryl gelatin microspheres versus polyvinyl alcohol particles. Cardiovasc Intervent Radiol 2003;26:375-378 https://doi.org/10.1007/s00270-003-0045-6
  22. Rasuli P, Jolly EE, Hammond I, French GJ, Preston R, Goulet S, et al. Superior hypogastric nerve block for pain control in outpatient uterine artery embolization. J Vasc Interv Radiol 2004;15:1423-1429 https://doi.org/10.1097/01.RVI.0000137406.09852.A4
  23. Nagao T, Ohwada T, Kitazono M, Ohshima K, Shimizu H, Katayama M. Thoracic epidural analgesia is effective in perioperative pain relief for uterine artery embolization. Masui 2005;54:156-159
  24. Ganguli S, Faintuch S, Salazar GM, Rabkin DJ. Postembolization syndrome: changes in white blood cell counts immediately after uterine artery embolization. J Vasc Interv Radiol 2008;19:443-445 https://doi.org/10.1016/j.jvir.2007.11.021
  25. Sandler AN, Baxter AD, Katz J, Samson B, Friedlander M, Norman P, et al. A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. analgesic, respiratory, and pharmacokinetic effects. Anesthesiology 1994;81:1169-1180 https://doi.org/10.1097/00000542-199411000-00010
  26. van Bastelaere M, Rolly G, Abdullah NM. Postoperative analgesia and plasma levels after transdermal fentanyl for orthopedic surgery: double-blind comparison with placebo. J Clin Anesth 1995;7:26-30 https://doi.org/10.1016/0952-8180(94)00000-T
  27. Strupp C, Sudhoff T, Germing U, Hunerliturkoglu A, Schneider P, Niederste-Hollenberg A, et al. Transdermal fentanyl during highdose chemotherapy and autologous stem cell support. Oncol Rep 2000;7:659-661
  28. Mantovani G, Curreli L, Maccio A, Massa E, Massa D, Mulas C, et al. Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report. Anticancer Res 1999;19:3495-3502